WEBSITE BSE:0 NSE: Inc. Year: 1998 Industry: Hotel, Resort & Restaurants My Bucket: Add Stock
Last updated: 15:45
No Notes Added Yet
1. Business Overview
Apollo Sindoori Hotels Ltd. primarily operates in the hospitality sector, focusing on managing and operating hotels and providing comprehensive hospitality services. The company's core business model involves offering lodging, food & beverage (F&B) services, and banquet facilities to a diverse clientele, including business travelers, tourists, and event attendees. It generates revenue through room tariffs, F&B sales, event bookings, and other related hospitality services. Given its name, there is a strong potential association with the Apollo Hospitals Group, suggesting a potential focus on catering to medical tourists, patient families, and corporate clients of the healthcare industry.
2. Key Segments / Revenue Mix
The primary revenue segment for Apollo Sindoori Hotels is Hospitality Services. This segment typically encompasses:
Room Revenue: Income from hotel room bookings.
Food & Beverage (F&B) Revenue: Sales from restaurants, cafes, in-room dining, and catering for events.
Banquet & Event Revenue: Income from hosting conferences, weddings, and other social or corporate events.
While specific breakdowns are not provided, the majority of revenue for a hotel company typically comes from a combination of room tariffs and F&B sales.
3. Industry & Positioning
The Indian hotel industry is diverse, encompassing luxury, upscale, mid-market, and budget segments, characterized by both large international and domestic chains, as well as independent hotels. It is cyclical and highly competitive. Apollo Sindoori Hotels likely positions itself in the mid-to-upscale segment, potentially leveraging its association with the Apollo brand for trust and quality. Its positioning could be strategic, focusing on locations near Apollo Hospitals facilities or other key commercial/tourist hubs, possibly targeting business travelers, domestic tourists, and medical tourism clientele. Compared to major national chains, it is likely a regional or specialized player.
4. Competitive Advantage (Moat)
Apollo Sindoori Hotels' potential competitive advantage (moat) could stem from:
Brand Association: A potential direct or indirect association with the renowned Apollo Hospitals Group could lend significant brand trust, reliability, and recognition, especially for medical tourism or corporate tie-ups within the healthcare ecosystem.
Strategic Locations: Hotels located strategically near major hospitals, business centers, or tourist attractions provide a natural demand base.
Service Quality: A consistent focus on service excellence can build customer loyalty, particularly in the mid-to-upscale segment.
Niche Market Focus: If it effectively caters to medical tourism or specific corporate clients, it can create a specialized demand pool.
5. Growth Drivers
Key factors that can drive growth for Apollo Sindoori Hotels over the next 3-5 years include:
Growth in Domestic Tourism & Business Travel: Rising disposable incomes, improved infrastructure, and a growing economy drive demand for leisure and business travel.
Medical Tourism: Leveraging any direct or indirect association with the Apollo Hospitals network could capture a significant share of the growing medical tourism market in India.
Expansion & Asset Optimization: Strategic expansion into new geographies or adding more properties (either owned or managed) to its portfolio.
Increased F&B & Banqueting Demand: Growth in corporate events, social gatherings, and food delivery services can boost ancillary revenues.
Government Initiatives: Policies promoting tourism infrastructure development and ease of travel within India.
6. Risks
Key business risks include:
Economic Downturn: The hospitality sector is highly sensitive to economic cycles and discretionary spending, making it vulnerable during recessions.
Intense Competition: The presence of numerous domestic and international hotel chains creates pricing pressure and market share battles.
Seasonality: Revenue can be highly seasonal, impacting cash flows.
Health Crises & Geopolitical Events: Pandemics (like COVID-19) or regional conflicts can severely disrupt travel and tourism.
High Fixed Costs: Hotels typically have high fixed costs (property, maintenance, staff) which can strain profitability during low occupancy periods.
Regulatory & Environmental Risks: Changes in tourism policies, local regulations, or environmental norms can impact operations.
7. Management & Ownership
Apollo Sindoori Hotels Ltd. is likely promoter-driven, typical of many Indian companies. Given the "Apollo" name, it is highly probable that the company's promoters have strong ties to the Apollo Hospitals Group, potentially implying experienced leadership with a long-term vision and a deep understanding of the Indian market, especially with respect to integrated services. The ownership structure would likely involve significant promoter holding, with the remaining shares held by institutional investors and the public.
8. Outlook
Apollo Sindoori Hotels is positioned in a dynamic Indian hospitality market. The tailwinds of increasing domestic tourism, rising disposable incomes, and potentially the robust medical tourism segment (especially if leveraging an Apollo Hospitals connection) offer significant growth opportunities. The post-pandemic recovery of travel and hospitality also provides a positive near-term outlook. However, the company operates in a highly competitive and cyclical industry, susceptible to economic slowdowns, geopolitical events, and intense competition from both large chains and smaller players. Success will depend on its ability to maintain service quality, strategically expand, manage costs efficiently, and effectively leverage any unique brand association or niche market focus to differentiate itself.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Market Cap ₹286 Cr.
Stock P/E 37
P/B 1.9
Current Price ₹1100.4
Book Value ₹ 589.9
Face Value 5
52W High ₹1605
Dividend Yield 0.23%
52W Low ₹ 950
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 128 | 135 | 135 | 128 | 135 | 141 | 138 | 138 | 150 | 161 |
| Other Income | 2 | 2 | 4 | 3 | 3 | 2 | 2 | 4 | 3 | 2 |
| Total Income | 130 | 138 | 139 | 130 | 138 | 143 | 140 | 143 | 152 | 163 |
| Total Expenditure | 122 | 129 | 131 | 123 | 129 | 136 | 135 | 133 | 143 | 152 |
| Operating Profit | 8 | 9 | 8 | 8 | 8 | 7 | 5 | 9 | 9 | 11 |
| Interest | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 4 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4 |
| Profit Before Tax | 4 | 5 | 4 | 4 | 4 | 3 | 1 | 5 | 5 | 1 |
| Provision for Tax | 2 | 1 | 3 | 2 | 2 | 1 | -1 | 1 | 2 | 0 |
| Profit After Tax | 2 | 4 | 2 | 1 | 2 | 2 | 2 | 4 | 3 | 1 |
| Adjustments | 0 | -0 | 0 | 0 | 0 | -0 | -0 | -0 | -0 | -0 |
| Profit After Adjustments | 2 | 4 | 2 | 1 | 2 | 2 | 2 | 4 | 3 | 1 |
| Adjusted Earnings Per Share | 6.9 | 14.3 | 6.6 | 5.7 | 8.5 | 7.2 | 8.3 | 15.2 | 11.9 | 2.9 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 141 | 186 | 133 | 140 | 165 | 193 | 169 | 208 | 367 | 519 | 542 | 587 |
| Other Income | 1 | 1 | 0 | 1 | 3 | 5 | 4 | 3 | 9 | 11 | 10 | 11 |
| Total Income | 142 | 187 | 133 | 141 | 168 | 199 | 172 | 211 | 376 | 530 | 552 | 598 |
| Total Expenditure | 133 | 178 | 121 | 130 | 154 | 185 | 164 | 196 | 351 | 495 | 523 | 563 |
| Operating Profit | 8 | 9 | 12 | 11 | 14 | 14 | 9 | 15 | 26 | 35 | 29 | 34 |
| Interest | 1 | 1 | 1 | 1 | 0 | 2 | 2 | 3 | 6 | 8 | 8 | 8 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 3 | 5 | 5 | 6 | 8 | 9 | 12 |
| Exceptional Income / Expenses | 0 | -5 | 0 | 1 | 0 | 0 | 0 | 0 | 9 | 0 | 0 | -4 |
| Profit Before Tax | 7 | 2 | 10 | 10 | 13 | 9 | 11 | 18 | 25 | 19 | 12 | 12 |
| Provision for Tax | 2 | 1 | 4 | 3 | 4 | 3 | 1 | 3 | 8 | 8 | 4 | 2 |
| Profit After Tax | 4 | 1 | 7 | 7 | 9 | 6 | 10 | 15 | 17 | 11 | 8 | 10 |
| Adjustments | 0 | 0 | 5 | 8 | 11 | 10 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 4 | 1 | 12 | 15 | 21 | 15 | 10 | 15 | 17 | 11 | 8 | 10 |
| Adjusted Earnings Per Share | 17 | 3.7 | 46.6 | 58.5 | 79.1 | 58.9 | 36.8 | 56.9 | 65 | 42.6 | 29.7 | 38.3 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 4% | 38% | 23% | 14% |
| Operating Profit CAGR | -17% | 25% | 16% | 14% |
| PAT CAGR | -27% | -19% | 6% | 7% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -16% | -7% | 10% | 25% |
| ROE Average | 6% | 10% | 11% | 13% |
| ROCE Average | 10% | 14% | 15% | 18% |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 25 | 26 | 32 | 48 | 68 | 79 | 88 | 102 | 120 | 135 | 146 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 2 | 0 | 0 | 0 | 0 | 4 | 4 | 3 | 48 | 2 | 2 |
| Other Non-Current Liabilities | 4 | 5 | 3 | 3 | 4 | 21 | 21 | 19 | 31 | 29 | 40 |
| Total Current Liabilities | 21 | 31 | 26 | 24 | 28 | 40 | 37 | 39 | 131 | 142 | 119 |
| Total Liabilities | 51 | 62 | 62 | 74 | 99 | 144 | 149 | 163 | 331 | 308 | 308 |
| Fixed Assets | 5 | 6 | 4 | 4 | 5 | 30 | 28 | 27 | 49 | 52 | 67 |
| Other Non-Current Assets | 6 | 8 | 18 | 25 | 35 | 45 | 55 | 61 | 27 | 26 | 30 |
| Total Current Assets | 40 | 47 | 40 | 46 | 59 | 69 | 66 | 75 | 254 | 230 | 211 |
| Total Assets | 51 | 62 | 62 | 74 | 99 | 144 | 149 | 163 | 331 | 308 | 308 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 4 | 2 | 2 | 2 | 8 | 15 | 20 | 20 | 21 | 18 | -22 |
| Cash Flow from Operating Activities | 3 | 6 | 8 | 18 | 21 | 22 | 17 | 18 | 2 | 14 | 21 |
| Cash Flow from Investing Activities | -4 | -4 | -9 | -10 | -13 | -21 | -12 | -12 | -47 | 6 | -3 |
| Cash Flow from Financing Activities | -1 | 0 | -0 | -1 | -1 | 2 | -3 | -4 | 41 | -59 | -12 |
| Net Cash Inflow / Outflow | -2 | 2 | -1 | 7 | 7 | 4 | 2 | 1 | -4 | -40 | 6 |
| Closing Cash & Cash Equivalent | 2 | 3 | 2 | 8 | 15 | 20 | 22 | 21 | 18 | -22 | -16 |
| # | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 16.98 | 3.73 | 46.56 | 58.5 | 79.07 | 58.9 | 36.79 | 56.94 | 65.05 | 42.57 | 29.71 |
| CEPS(Rs) | 21.41 | 9.31 | 28.94 | 29.75 | 39.66 | 33.34 | 54.62 | 75.63 | 87.83 | 72.38 | 65.57 |
| DPS(Rs) | 1.5 | 0 | 1.5 | 2.5 | 3 | 2 | 1.25 | 1.5 | 1.5 | 2 | 2.5 |
| Book NAV/Share(Rs) | 95.99 | 98.98 | 124.52 | 183.33 | 259.66 | 305.52 | 338.04 | 393.67 | 461.56 | 519.53 | 561.49 |
| Core EBITDA Margin(%) | 5.51 | 4.41 | 8.77 | 7 | 6.7 | 4.31 | 2.95 | 5.71 | 4.46 | 4.7 | 3.51 |
| EBIT Margin(%) | 5.2 | 1.7 | 8.21 | 7.58 | 7.97 | 5.44 | 7.78 | 9.73 | 8.44 | 5.24 | 3.69 |
| Pre Tax Margin(%) | 4.78 | 1.07 | 7.75 | 7.16 | 7.84 | 4.59 | 6.53 | 8.47 | 6.79 | 3.69 | 2.23 |
| PAT Margin (%) | 3.13 | 0.52 | 4.98 | 4.86 | 5.65 | 2.92 | 5.67 | 7.12 | 4.61 | 2.13 | 1.43 |
| Cash Profit Margin (%) | 3.95 | 1.3 | 5.67 | 5.53 | 6.23 | 4.48 | 8.42 | 9.46 | 6.22 | 3.62 | 3.15 |
| ROA(%) | 8.58 | 1.71 | 10.72 | 9.97 | 10.79 | 4.66 | 6.53 | 9.47 | 6.85 | 3.47 | 2.51 |
| ROE(%) | 17.69 | 3.82 | 22.76 | 16.99 | 16.23 | 7.69 | 11.43 | 15.56 | 15.21 | 8.68 | 5.5 |
| ROCE(%) | 25.08 | 10.82 | 32 | 24.31 | 22.72 | 13.37 | 14.09 | 19.58 | 18.36 | 12.64 | 9.99 |
| Receivable days | 79.29 | 65.92 | 95.87 | 86.92 | 78.22 | 71.75 | 81.07 | 64.18 | 59.94 | 61.64 | 59.34 |
| Inventory Days | 4.01 | 2.87 | 3.18 | 2.25 | 2.1 | 3.52 | 4.88 | 3.75 | 3.13 | 2.5 | 2.13 |
| Payable days | 70.73 | 62.01 | 100.23 | 105.26 | 101.74 | 94.12 | 117.33 | 79.76 | 70.59 | 75.06 | 57.34 |
| PER(x) | 6.02 | 29.13 | 6.65 | 10.75 | 11.16 | 6.66 | 15.43 | 14.37 | 16.17 | 39.16 | 40.44 |
| Price/Book(x) | 1.06 | 1.1 | 2.49 | 3.43 | 3.4 | 1.28 | 1.68 | 2.08 | 2.28 | 3.21 | 2.14 |
| Dividend Yield(%) | 1.47 | 0 | 0.48 | 0.4 | 0.34 | 0.51 | 0.22 | 0.18 | 0.14 | 0.12 | 0.21 |
| EV/Net Sales(x) | 0.19 | 0.14 | 0.64 | 1.11 | 1.29 | 0.48 | 0.8 | 0.94 | 0.63 | 0.75 | 0.49 |
| EV/Core EBITDA(x) | 3.1 | 2.76 | 7.2 | 14.47 | 15.13 | 6.81 | 15.55 | 13.31 | 8.91 | 11.15 | 9.04 |
| Net Sales Growth(%) | 0 | 31.78 | -28.58 | 5.36 | 18.23 | 16.95 | -12.79 | 23.23 | 76.5 | 41.53 | 4.31 |
| EBIT Growth(%) | 0 | -56.96 | 244.89 | -2.71 | 24.34 | -20.22 | 24.79 | 54.22 | 53.07 | -12.24 | -26.48 |
| PAT Growth(%) | 0 | -78.07 | 582.9 | 2.8 | 37.44 | -39.56 | 69.34 | 54.78 | 14.25 | -34.56 | -30.21 |
| EPS Growth(%) | 0 | -78.07 | 1149.77 | 25.66 | 35.15 | -25.51 | -37.54 | 54.78 | 14.25 | -34.56 | -30.21 |
| Debt/Equity(x) | 0.17 | 0.13 | 0.2 | 0.01 | 0 | 0.13 | 0.1 | 0.07 | 0.9 | 0.5 | 0.35 |
| Current Ratio(x) | 1.89 | 1.54 | 1.53 | 1.94 | 2.14 | 1.73 | 1.8 | 1.92 | 1.94 | 1.62 | 1.76 |
| Quick Ratio(x) | 1.83 | 1.49 | 1.49 | 1.9 | 2.1 | 1.67 | 1.75 | 1.86 | 1.91 | 1.59 | 1.74 |
| Interest Cover(x) | 12.28 | 2.71 | 18.03 | 18.33 | 60.15 | 6.46 | 6.24 | 7.72 | 5.12 | 3.38 | 2.52 |
| Total Debt/Mcap(x) | 0.16 | 0.12 | 0.08 | 0 | 0 | 0.1 | 0.06 | 0.04 | 0.39 | 0.16 | 0.17 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 64.68 | 64.68 | 64.68 | 64.68 | 64.68 | 64.68 | 64.68 | 64.68 | 64.68 | 64.68 |
| FII | 0.06 | 0.11 | 0.1 | 0 | 0.03 | 0.01 | 0.04 | 0 | 0 | 0 |
| DII | 0 | 0.27 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 35.26 | 34.94 | 35.23 | 35.32 | 35.29 | 35.31 | 35.28 | 35.32 | 35.32 | 35.32 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.17 | 0.17 | 0.17 | 0.17 | 0.17 | 0.17 | 0.17 | 0.17 | 0.17 | 0.17 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 0.26 | 0.26 | 0.26 | 0.26 | 0.26 | 0.26 | 0.26 | 0.26 | 0.26 | 0.26 |
* The pros and cons are machine generated.
You May Also Know About
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.